Spotlight Interview With Nektaria Karavas, Business Development Director, Nasal Vaccines, Antivirals and Immunostimulants at Aptar Pharma

 

Nektaria Karavas, Business Development Director, Nasal Vaccines, Antivirals and Immunostimulants at Aptar Pharma

 

 

Why did you decide to do a webinar with us?

With the pandemic taking the world by storm, cancellations of physical events, and people being required to work from home, webinars are great way to engage with our audience all around the world. We can stay connected. We give as well as receive information, all in a relative short time frame, and in the comfort of our own homes! Or, offices.

What will the audience gain from attending your webinar?

We hope the attendees will better understand Aptar Pharma’s capabilities, how we can work together to de-risk the development process and support our customers in their drug development journey. It’s not just from the device perspective but to provide proven and complete drug delivery solutions and services, end to end, to approval and of course post launch.

What are you hoping to achieve in the future in your personal and professional life?

In this time of COVID, we all know someone who has been touched and affected by this virus, so from a professional and personal level, for Aptar Pharma to be able to be part of the delivery solution, a solution that could potentially benefit so many people around us, how gratifying would that be.

How did you get into the industry and what do you most enjoy about your role?

By chance, and after being with Aptar for over 15 years, I am still learning, exchanging ideas and excited to go to work every day.

Where is your favorite place in the world and why?

I don’t have one specific favorite place in the world, there are just too many to name and all have their own special magic. Travelling is all about learning, discovering the history, the culture and the food. Travel provides us with new perspectives on life.

Join Nektaria Karavas & Julie D. Suman, RPh, PhD on a webinar entitled Intranasal Immunization: Promises and Challenges
 by Aptar Pharma on 25th of March at 9AM London/2:30PM Mumbai/5PM Beijing & 3:30PM London/4:30PM Paris/11:30AM New York

Leave a Reply

Your email address will not be published. Required fields are marked *